Trastuzumab - emtansine for HER2-positive breast cancer patients and development of new therapies

Authors
Category Primary study
JournalGastric and Breast Cancer
Year 2019
This article has no abstract
Epistemonikos ID: 32a9559869242ed57eb1ef18dbcc35ae986249cf
First added on: Feb 11, 2025